Current disease status-Recurrent cancer - Page 10 of 19 Posts on Medivizor
Navigation Menu

Current disease status-Recurrent cancer Posts on Medivizor

Could counting immune cells help predict colorectal cancer patient outcome?

Could counting immune cells help predict colorectal cancer patient outcome?

Posted by on Jun 10, 2015 in Colorectal cancer | 0 comments

In a nutshell The authors examined whether eosinophils (white blood cells normally used to fight infections) levels in or around a colorectal tumor can help predict patient outcome.  Some background Colorectal cancer is often classified using the tumor node metastasis system (TNM system). This system depends upon the assessment of primary...

Read More

‘Stops and starts’ – an acceptable method of administering hormone therapy in prostate cancer?

‘Stops and starts’ –  an acceptable method of administering hormone therapy in prostate cancer?

Posted by on May 13, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effect of degarelix in treating prostate cancer.  Some background Hormone therapy is a prostate cancer treatment that targets the male sex hormones active in prostate cancer, such as testosterone. Degarelix (Firmagon) is a drug used in hormone therapy that reduces the levels of testosterone to...

Read More

How does secondary breast cancer differ from primary breast cancer in younger patients?

How does secondary breast cancer differ from primary breast cancer in younger patients?

Posted by on Apr 21, 2015 in Breast cancer | 0 comments

In a nutshell This paper compared primary and secondary breast cancers in adolescents and young adults. Some background Primary breast cancer refers to the first cancer that starts growing from the breast. Secondary breast cancer refers to breast cancer on the other breast that did not occur at the same time as the inital cancer, breast cancer...

Read More

Immune cell therapy in non-small cell lung cancer

Posted by on Apr 16, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine the effect of cytokine-induced killer cells for treatment of non-small cell lung cancer.  Some background Cytokine-induced killer cells (CIK) are man-made immune cells (fight infection and disease) that can recognize infected or cancerous cells in the absence of other immune cells, which allows for...

Read More

Hormone therapy in prostate cancer treatment

Hormone therapy in prostate cancer treatment

Posted by on Apr 8, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to identify emerging and current hormone treatments available for prostate cancer. Some background Male hormones are active in healthy cell growth and play a large role in cancer development in patients with prostate cancer by aiding cancer cell growth. Hormone therapy targets the male sex hormones produced during...

Read More